甲磺酸奈非那韦
|
N493150-50mg
|
≥96% |
159989-65-8 |
50mg
|
¥ 1555.9
|
现货 |
阿拉丁 |
甲磺酸奈非那韦
|
N493150-250mg
|
≥96% |
159989-65-8 |
250mg
|
¥ 5355.9
|
现货 |
阿拉丁 |
甲磺酸奈非那韦
|
N493150-10mg
|
≥96% |
159989-65-8 |
10mg
|
¥ 885.9
|
现货 |
阿拉丁 |
甲磺酸奈非那韦
|
N493150-100mg
|
≥96% |
159989-65-8 |
100mg
|
¥ 2574.9
|
现货 |
阿拉丁 |
N-丙酰基-L-半胱氨酸三氟乙酸盐
|
N491747-100mg
|
≥98% |
2885-79-2 |
100mg
|
¥ 2780.9
|
期货,请咨询 |
阿拉丁 |
新植二烯
|
N348031-5mg
|
≥90% |
504-96-1 |
5mg
|
¥ 999.9
|
现货 |
阿拉丁 |
新植二烯
|
N348031-1mg
|
≥90% |
504-96-1 |
1mg
|
¥ 299.9
|
现货 |
阿拉丁 |
NAEPA
|
N347152-50mg
|
Moligand™, ≥98% |
24435-25-4 |
50mg
|
¥ 8341.9
|
现货 |
阿拉丁 |
NAEPA
|
N347152-2mg
|
Moligand™, ≥98% |
24435-25-4 |
2mg
|
¥ 740.9
|
现货 |
阿拉丁 |
NAEPA
|
N347152-10mg
|
Moligand™, ≥98% |
24435-25-4 |
10mg
|
¥ 2409.9
|
现货 |
阿拉丁 |
N-肉豆蔻酰甘氨酸
|
N338969-10mg
|
≥98% |
14246-55-0 |
10mg
|
¥ 411.9
|
现货 |
阿拉丁 |
4-硝基苯基二氯磷酸酯
|
N333107-25g
|
≥98% |
777-52-6 |
25g
|
¥ 1937.9
|
现货 |
阿拉丁 |
4-硝基苯基二氯磷酸酯
|
N333107-1g
|
≥98% |
777-52-6 |
1g
|
¥ 155.9
|
现货 |
阿拉丁 |
N-(3-溴苯基)-N-苯基-[1,1-联苯]-4-胺
|
N292600-1g
|
≥98% |
1134188-19-4 |
1g
|
¥ 117.9
|
现货 |
阿拉丁 |
N-(3-溴苯基)-N-苯基-[1,1-联苯]-4-胺
|
N292600-100g
|
≥98% |
1134188-19-4 |
100g
|
¥ 4078.9
|
现货 |
阿拉丁 |
双-4-(N-咔唑基)苯基)苯基氧化膦
|
N290042-500mg
|
升华级, ≥99% |
1233407-28-7 |
500mg
|
¥ 2677.9
|
现货 |
阿拉丁 |
双-4-(N-咔唑基)苯基)苯基氧化膦
|
N290042-25mg
|
升华级, ≥99% |
1233407-28-7 |
25mg
|
¥ 308.9
|
现货 |
阿拉丁 |
双-4-(N-咔唑基)苯基)苯基氧化膦
|
N290042-100mg
|
升华级, ≥99% |
1233407-28-7 |
100mg
|
¥ 823.9
|
现货 |
阿拉丁 |
NS 9283,α4β2nAChRs的正变构调节剂
|
N288399-5mg
|
Moligand™, ≥99%(HPLC) |
913830-15-6 |
5mg
|
¥ 1324.9
|
现货 |
阿拉丁 |
NS 9283,α4β2nAChRs的正变构调节剂
|
N288399-25mg
|
Moligand™, ≥99%(HPLC) |
913830-15-6 |
25mg
|
¥ 3939.9
|
现货 |
阿拉丁 |
NNC 05-2090 盐酸盐
|
N286590-5mg
|
≥98%(HPLC) |
184845-18-9 |
5mg
|
¥ 1338.9
|
现货 |
阿拉丁 |
NNC 05-2090 盐酸盐
|
N286590-25mg
|
≥98%(HPLC) |
184845-18-9 |
25mg
|
¥ 5149.9
|
现货 |
阿拉丁 |
NNC 05-2090 盐酸盐
|
N286590-100mg
|
≥98%(HPLC) |
184845-18-9 |
100mg
|
¥ 14883.9
|
现货 |
阿拉丁 |
神经肽Y(NPY)(人类,大鼠)
|
N275391-5mg
|
Moligand™, ≥98% |
90880-35-6 |
5mg
|
¥ 4119.9
|
现货 |
阿拉丁 |